COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

White House Announces Over $1.6 Billion to Increase Availability of COVID-19 Testing

calculator concept covid19 testing calculator
Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on pinterest
Pinterest
Share on whatsapp
WhatsApp
Share on email
Email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

Increased funds to expand COVID-19 testing focus on addressing supply chain issues and monitoring for new variants

The White House announced Feb. 17, 2021, the allocation of new funds to expand access to COVID-19 testing. This new initiative will involve providing over $1.6 billion and is designed to help increase the public’s accessibility to testing, reduce supply chain shortages for clinical laboratories, and better monitor new variants.

“We need to test broadly and rapidly to turn the tide of this pandemic,” said Carole Johnson, the White House’s Covid-19 Testing Coordinator. “But we still don’t have enough testing and we don’t have enough testing in all the places it needs to be.”

Sources of Federal Funding Moving in Three Directions

Of the over $1.6 billion being allocated to COVID-19 testing, the breakdown for these funds includes:

  1. $650 million from the US Department of Health and Human Services (HHS) and the US Department of Defense (DOD) to expand testing in schools and underserved congregate settings.
  2. $815 million from HHS and the DOD to increase the domestic manufacturing of COVID-19 testing supplies such as reagents and transport containers. This increased funding is designed to reduce supply shortages for clinical laboratories.
  3. $200 million from the Centers for Disease Control and Prevention (CDC) to expand and promote genomic sequencing of SARS-CoV-2. This funding is designed to detect and track variants circulating in the US.

These funds will help both clinical laboratories and public health labs to have better access to the resources needed to increase COVID-19 testing.

Related Resources:

NPR: White House Announces Expanded COVID-19 Testing, Manufacturing And Virus Sequencing

White House: Briefing Feb. 17, 2021

COVID-19 TESTING DATA

Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at rmichel@darkreport.com.

Sincerely,

Robert L. Michel
President, Founder
The Dark Intelligence Group